PACB – Pacific Biosciences of California, Inc.

Pacific Biosciences of Californ

PACB

$1.33

Name : Pacific Biosciences of Californ

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $399,113,056.00

EPSttm : -2.74

Pacific Biosciences of Californ

$1.33

3.62%

$0.05

Float Short %

16.8

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

-0.01

EPS Last/This Y

0.49

EPS This/Next Y

0.11

Price

1.33

Target Price

1.96

Analyst Recom

2.31

Performance Q

19.82

Relative Volume

0.8

Beta

2.17

Ticker: PACB

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-04	PACB	1.6	0.32	0.07	95656
2025-07-07	PACB	1.475	0.33	0.71	93670
2025-07-08	PACB	1.5	0.33	0.49	92971
2025-07-09	PACB	1.49	0.33	0.02	92938
2025-07-10	PACB	1.495	0.33	0.03	93819
2025-07-11	PACB	1.465	0.33	0.00	93799
2025-07-14	PACB	1.47	0.33	0.04	93724
2025-07-15	PACB	1.46	0.33	0.66	93724
2025-07-16	PACB	1.485	0.33	0.57	94322
2025-07-17	PACB	1.39	0.32	0.87	93691
2025-07-18	PACB	1.365	0.32	0.79	93985
2025-07-21	PACB	1.445	0.31	0.21	91319
2025-07-22	PACB	1.63	0.31	0.11	91702
2025-07-23	PACB	1.695	0.31	0.06	92143
2025-07-24	PACB	1.535	0.31	0.66	92539
2025-07-25	PACB	1.535	0.31	0.09	92858
2025-07-28	PACB	1.645	0.31	0.05	93089
2025-07-29	PACB	1.55	0.31	0.69	93458
2025-07-30	PACB	1.49	0.31	0.31	93654
2025-07-31	PACB	1.375	0.31	0.81	93711
2025-08-01	PACB	1.32	0.32	0.03	95909
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-04	PACB	1.60	17.5	249.4	-0.64
2025-07-07	PACB	1.48	17.5	282.6	-0.64
2025-07-08	PACB	1.50	17.5	261.3	-0.64
2025-07-09	PACB	1.48	17.5	268.4	-0.64
2025-07-10	PACB	1.50	17.5	262.7	-0.64
2025-07-11	PACB	1.47	17.5	267.0	-0.64
2025-07-14	PACB	1.46	17.5	267.0	-0.64
2025-07-15	PACB	1.44	17.5	268.4	-0.64
2025-07-16	PACB	1.49	17.5	259.0	-0.64
2025-07-17	PACB	1.39	17.5	279.8	-0.64
2025-07-18	PACB	1.37	17.5	268.5	-0.64
2025-07-21	PACB	1.45	17.5	253.6	-0.64
2025-07-22	PACB	1.62	17.5	241.7	-0.64
2025-07-23	PACB	1.69	17.5	256.1	-0.64
2025-07-24	PACB	1.54	17.5	285.4	-0.64
2025-07-25	PACB	1.54	17.5	266.3	-0.64
2025-07-28	PACB	1.65	17.2	249.5	-0.64
2025-07-29	PACB	1.54	17.2	279.0	-0.64
2025-07-30	PACB	1.49	17.2	273.5	-0.64
2025-07-31	PACB	1.38	17.2	281.2	-0.64
2025-08-01	PACB	1.33	17.2	272.5	-0.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-04	PACB	-1.23	-12.68	15.01
2025-07-07	PACB	-1.23	-12.68	15.01
2025-07-08	PACB	-1.23	-12.68	15.01
2025-07-09	PACB	-1.23	-12.68	15.01
2025-07-10	PACB	-1.23	-12.68	15.01
2025-07-11	PACB	-1.13	-12.68	17.93
2025-07-14	PACB	-1.13	-12.61	17.93
2025-07-15	PACB	-1.13	-12.61	17.93
2025-07-16	PACB	-1.13	-12.61	17.93
2025-07-17	PACB	-1.13	-12.61	17.93
2025-07-18	PACB	-1.13	-12.61	17.93
2025-07-21	PACB	-1.13	-12.81	17.93
2025-07-22	PACB	-1.13	-12.81	17.93
2025-07-23	PACB	-1.13	-12.81	17.93
2025-07-24	PACB	-1.13	-12.81	17.93
2025-07-25	PACB	-1.13	-12.81	16.80
2025-07-28	PACB	-1.13	-13.00	16.80
2025-07-29	PACB	-1.13	-13.00	16.80
2025-07-30	PACB	-1.13	-13.00	16.80
2025-07-31	PACB	-1.13	-13.00	16.80
2025-08-01	PACB	-1.13	-13.00	16.80
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.15

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

-1.13

Institutional Transactions

-13

Beta

2.17

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.5

Max Drawdown 5-Year %

-98.2

Target Price

1.96

P/E

Forward P/E

PEG

P/S

2.62

P/B

4.35

P/Free Cash Flow

EPS

-2.77

Average EPS Est. Cur. Y

-0.64

EPS Next Y. (Est.)

-0.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-430.93

Relative Volume

0.8

Return on Equity vs Sector %

-741.5

Return on Equity vs Industry %

-736

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

272.5

Pacific Biosciences of Californ

Sector: Healthcare

Industry: Medical Devices

Employees: 575

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, Sequel, Sequel II, and Sequel IIe instruments which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. It serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

stock quote shares PACB – Pacific Biosciences of California, Inc. Stock Price stock today

news today PACB – Pacific Biosciences of California, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PACB – Pacific Biosciences of California, Inc. yahoo finance google finance

stock history PACB – Pacific Biosciences of California, Inc. invest stock market

stock prices PACB premarket after hours

ticker PACB fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

PACB – Pacific Biosciences of California, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PACB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y